- Home
- ANTX vs DAVA Comparison
ANTX vs DAVA Comparison
Compare ANTX & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANTX | DAVA |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 159.1M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ANTX | DAVA |
|---|---|---|
| Price | $4.92 | $2.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $2.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 353.1K | 277.6K |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $2.55 |
| 52 Week High | $6.91 | $14.99 |
Technical Indicators
Market Signals| Indicator | ANTX | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 41.14 |
| Support Level | $3.91 | $2.70 |
| Resistance Level | $5.13 | $3.03 |
| Average True Range (ATR) | 0.36 | 0.12 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 80.00 | 3.03 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.